Skip to main content

About Michael B. Chancellor, M.D.

Dr. Chancellor has written over 550 peer-reviewed articles and book chapters in journals including The Journal of Urology, Urology, Gene Therapy, and Lancet. He has also written 11 books and serves on the editorial board of 12 scientific journals. A prolific author and researcher, Dr. Chancellor has gained national and international recognition in the areas of stem cell and tissue engineering as well as drug discovery. He was the first urologist to use botulinum toxin to treat lower urinary tract dysfunction. His inventions founded Cook MyoSite, Inc., which is now conducting multicenter North American trials using adult autologous muscle-derived stem cells to treat stress urinary incontinence. Dr. Chancellor also founded Lipella Pharmaceuticals, Inc., a biopharmaceutical company focusing on localized therapy and advance drug delivery.

Positions

2014 - Present Director, The Robert B. and Ann S. Aikens Center for Neurology Research
to
2009 - Present Professor, Oakland University William Beaumont School of Medicine ‐ Department of Urology
to
2008 - Present Director of Neurourology Program, Beaumont Department of Urology
to

Curriculum Vitae


Disciplines



$
to
Enter a valid date range.

to
Enter a valid date range.

Education

to
1989 - 1990 Fellowship, College of Physicians and Surgeons, Columbia University ‐ Neuro-Urology
to
1985 - 1988 Resident, Urology, University of Michigan Medical Center
to
1984 - 1985 Resident, Surgery, University of Michigan Medical Center
to
1983 - 1984 Intern, Surgery, University of Michigan Medical Center
to
1979 - 1983 M.D., Medical College of Wisconsin
to
1976 - 1979 B.S., University of Michigan - Ann Arbor ‐ Biology
to


Contact Information

3535 West 13 Mile Road
Medical Office Building,
Suite 404
Royal Oak, MI 48073

248-551-3535


Recent Works (5)

Research Works (24)